Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Dr Anita Barzegar Fallah

PositionResearch Assistant
QualificationsPharmD PhD
Research summaryMolecular and cellular neuroscience, angiogenesis and tumor progression.

Publications

Gandhi, K., Barzegar-Fallah, A., Banstola, A., Rizwan, S. B., & Reynolds, J. N. J. (2022). Ultrasound-mediated blood-brain barrier disruption for drug delivery: A systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies. Pharmaceutics, 14, 833. doi: 10.3390/pharmaceutics14040833

Alimoradi, H., Thomas, A., Lyth, D. D. B., Barzegar-Fallah, A., Matikonda, S. S., Gamble, A. B., & Giles, G. I. (2022). SMA-BmobaSNO: An intelligent photoresponsive nitric oxide releasing polymer for drug nanoencapsulation and targeted delivery. Nanotechnology. Advance online publication. doi: 10.1088/1361-6528/ac4eb0

Barzegar-Fallah, A., Alimoradi, H., Dunlop, J. L., Torbati, E., & Baird, S. K. (2021). Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-κB downregulation. Cell Biology & Toxicology. Advance online publication. doi: 10.1007/s10565-021-09667-0

Barzegar-Fallah, A., Houlton, J., Barwick, D., Shavandi, A., Ali, M. A., Clarkson, A. N., & Alimoradi, H. (2021). From barriers to bridges: Glycans in naonparenteral nanomedicines. In P. Kesharwani, S. Taurin & K. Greish (Eds.), Theory and applications of nonparenteral nanomedicines. (pp. 467-487). London, UK: Elsevier. doi: 10.1016/B978-0-12-820466-5.00019-3

Mohammad, Y., Barzegar Fallah, A., Reynolds, J. N. J., Boyd, B. J., & Rizwan, S. B. (2020). Steric stabilisers govern the colloidal and chemical stability but not in vitro cellular toxicity of linoleoylethanolamide cubosomes. Colloids & Surfaces B, 192, 111063. doi: 10.1016/j.colsurfb.2020.111063

Barzegar-Fallah, A., Houlton, J., Barwick, D., Shavandi, A., Ali, M. A., Clarkson, A. N., & Alimoradi, H. (2021). From barriers to bridges: Glycans in naonparenteral nanomedicines. In P. Kesharwani, S. Taurin & K. Greish (Eds.), Theory and applications of nonparenteral nanomedicines. (pp. 467-487). London, UK: Elsevier. doi: 10.1016/B978-0-12-820466-5.00019-3

Chapter in Book - Research

Alimoradi, H., Thomas, A., Lyth, D. D. B., Barzegar-Fallah, A., Matikonda, S. S., Gamble, A. B., & Giles, G. I. (2022). SMA-BmobaSNO: An intelligent photoresponsive nitric oxide releasing polymer for drug nanoencapsulation and targeted delivery. Nanotechnology. Advance online publication. doi: 10.1088/1361-6528/ac4eb0

Journal - Research Article

Gandhi, K., Barzegar-Fallah, A., Banstola, A., Rizwan, S. B., & Reynolds, J. N. J. (2022). Ultrasound-mediated blood-brain barrier disruption for drug delivery: A systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies. Pharmaceutics, 14, 833. doi: 10.3390/pharmaceutics14040833

Journal - Research Article

Barzegar-Fallah, A., Alimoradi, H., Dunlop, J. L., Torbati, E., & Baird, S. K. (2021). Serotonin type-3 receptor antagonists selectively kill melanoma cells through classical apoptosis, microtubule depolymerisation, ERK activation, and NF-κB downregulation. Cell Biology & Toxicology. Advance online publication. doi: 10.1007/s10565-021-09667-0

Journal - Research Article

Mohammad, Y., Barzegar Fallah, A., Reynolds, J. N. J., Boyd, B. J., & Rizwan, S. B. (2020). Steric stabilisers govern the colloidal and chemical stability but not in vitro cellular toxicity of linoleoylethanolamide cubosomes. Colloids & Surfaces B, 192, 111063. doi: 10.1016/j.colsurfb.2020.111063

Journal - Research Article

Alimoradi, H., Barzegar-Fallah, A., Sammut, I. A., Griesh, K., & Giles, G. I. (2019). Encapsulation of tDodSNO generates a photoactivated nitric oxide releasing nanoparticle for localized control of vasodilation and vascular hyperpermeability. Free Radical Biology & Medicine, 130, 297-305. doi: 10.1016/j.freeradbiomed.2018.10.433

Journal - Research Article

Alimoradi, H., Greish, K., Barzegar-Fallah, A., Alshaibani, L., & Pittalà, V. (2018). Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity. International Journal of Nanomedicine, 13, 7771-7787. doi: 10.2147/ijn.S187089

Journal - Research Article

Barzegar-Fallah, N., Baery, N., Soleymankhani, M., Malekmohammadi, N., Alimoradi, H., Parsa, A., & Barzegar-Fallah, A. (2016). Kelussia odoratissima Mozaff attenuates thromboembolic brain injury, possibly due to its Z-ligustilide content. Brain Injury, 30(7), 926-932. doi: 10.3109/02699052.2016.1144083

Journal - Research Article

Barzegar-Fallah, A., Alimoradi, H., Asadi, F., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats. Clinical & Experimental Pharmacology & Physiology, 42(4), 361-368. doi: 10.1111/1440-1681.12373

Journal - Research Article

Barzegar-Fallah, A., Alimoradi, H., Razmi, A., Dehpour, A. R., Asgari, M., & Shafiei, M. (2015). Inhibition of calcineurin/NFAT pathway plays an essential role in renoprotective effect of tropisetron in early stage of diabetic nephropathy. European Journal of Pharmacology, 767, 152-159. doi: 10.1016/j.ejphar.2015.10.019

Journal - Research Article

Alimoradi, H., Barzegar-Fallah, A., Sammut, I. A., Griesh, K., & Giles, G. I. (2018). Data characterizing the biophysical and nitric oxide release properties of the tDodSNO: Styrene maleic anhydride nanoparticle SMA-tDodSNO [Data article]. Data in Brief, 21, 1771-1775. doi: 10.1016/j.dib.2018.10.149

Journal - Research Other

More publications...